Buttonwood Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,976
Closed -$221K 106
2024
Q1
$221K Sell
7,976
-1,554
-16% -$43.1K 0.1% 100
2023
Q4
$274K Sell
9,530
-297
-3% -$8.98K 0.15% 88
2023
Q3
$326K Sell
9,827
-96
-1% -$3.4K 0.21% 82
2023
Q2
$364K Buy
9,923
+562
+6% +$21.9K 0.23% 76
2023
Q1
$382K Buy
9,361
+1
+0% +$43 0.3% 60
2022
Q4
$480K Sell
9,360
-73
-0.8% -$3.5K 0.4% 55
2022
Q3
$405K Buy
9,433
+1
+0% +$49 0.37% 54
2022
Q2
$495K Buy
9,432
+4,101
+77% +$209K 0.45% 51
2022
Q1
$276K Buy
+5,331
New +$277K 0.25% 59

Other funds holding PFE

Buttonwood Financial Advisors's PFE Position: Q2 2024 in Review

Buttonwood Financial Advisors sold out of Pfizer (PFE) in Q2 2024, closing a stake of 7,976 shares — an estimated $221K sold.

Buttonwood Financial Advisors first reported a position in PFE in Q1 2022 and held it in 9 quarters. The position peaked at $495K in Q2 2022. 2,874 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • Buttonwood Financial Advisors reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
  • Buttonwood Financial Advisors sold 7,976 Pfizer shares in Q2 2024, an estimated $221K.
  • Buttonwood Financial Advisors first reported a position in Pfizer in Q1 2022 and held it in 9 quarters.
  • Buttonwood Financial Advisors's Pfizer position peaked at $495K in Q2 2022.
  • 2,874 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Buttonwood Financial Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.